Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 10.4B | 11.0B | 11.7B | 10.2B |
Cost of revenue | 4.6B | 4.9B | 5.2B | 4.5B |
Gross profit | 5.8B | 6.0B | 6.5B | 5.8B |
Operating expense | ||||
Research & development | 2.2B | 2.2B | 2.2B | 2.3B |
Selling general and admin | 771M | 706M | 723M | 761M |
Other operating expenses | — | — | — | — |
Operating income | 2.8B | 3.1B | 3.6B | 2.5B |
Non operating interest income | ||||
Income | 160M | 167M | 169M | 185M |
Expense | 168M | 163M | 163M | 180M |
Other income expense | 198M | -19M | 74M | 56M |
Pretax income | 3.0B | 3.1B | 3.6B | 2.6B |
Tax provision | 286M | 293M | 455M | -319M |
Net income | 2.7B | 2.8B | 3.2B | 2.9B |
Basic EPS | 2.4 | 2.6 | 2.9 | 2.6 |
Diluted EPS | 2.4 | 2.5 | 2.8 | 2.6 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 3.4B | 3.7B | 4.2B | 3.2B |
Net income from continuing op. | 2.7B | 2.8B | 3.2B | 2.9B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |